Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 6.2M | Sales 2022 | 1.5M | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -25M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
-1.78% | 104B | |
+1.81% | 97.42B | |
+0.35% | 22.2B | |
-17.08% | 21.23B | |
-10.51% | 18.33B | |
-42.33% | 16.35B | |
-18.56% | 15.06B | |
+5.16% | 13.98B | |
+27.17% | 11.66B |